PetLife Pharmaceuticals, Inc. Convertible Notes Payable, Current
PetLife Pharmaceuticals, Inc. had Convertible Notes Payable, Current of $212.93 thousand as of 2018-02-28, per its 10-Q filed 2018-07-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2018-07-17
- 2018-02-28: Convertible Notes Payable, Current $212.93K.
- 2017-11-30: Convertible Notes Payable, Current $110.53K.
- 2017-08-31: Convertible Notes Payable, Current $57.32K.
- 2017-05-31: Convertible Notes Payable, Current $92.50K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2018-02-28 | $212.93K 10-Q · filed 2018-07-17 |
| 2017-11-30 | $110.53K 10-Q · filed 2018-01-22 |
| 2017-08-31 | $57.32K 10-Q · filed 2018-07-17 |
| 2017-05-31 | $92.50K 10-Q · filed 2017-07-18 |
| 2017-02-28 | $92.50K 10-Q · filed 2017-04-14 |